Back to 
Goldman Sachs Group Inc.
Goldman Sachs Group Inc.
MDGL
Showing 8 of 17 quarters
Position history for Goldman Sachs Group Inc.'s holdings in Madrigal Pharmaceuticals, Inc.
Yes. Goldman Sachs holds 246,280 shares of MDGL, worth $132.2M, as of its Q2 2026 13F filing. It reduced the position by 31,091 shares (-11.2%) from Q1 2026. Goldman Sachs has held MDGL in every 13F on record since Q2 2022, 17 quarterly filings.
Current Value
$132.2M
Current Shares
246,280
Total Value Change
+$81.4M
Total Shares Change
+6,500
Quarter-by-Quarter History
Other major holders of MDGL: Baker Bros. Advisors LP, RTW Investments, LP